Champix 0.5 / 1 mg Tablet 25pcs

Product description: Chamepex is used for smoking cessation in adults. Usage instructions: The recommended dose is 1 mg of varenicline twice daily after a one-week titration as follows: Days 1-3: 0.5 mg once daily, Days 4-7: 0.5 mg twice daily, Day 8 (end of treatment): 1 mg twice daily. The patient should schedule a stop date for smoking. Chamepex doses should usually start 1-2 weeks before this date. Patients should be treated with Chamepex for 12 weeks. Warnings and precautions: Hypersensitivity to the active substance or any of the excipients. Clinical signs include swelling of the face and mouth (tongue, lips, gums) and neck (throat, larynx) and extremities. Smoking cessation effect: Physiological changes resulting from quitting smoking, with or without treatment with Chamepex, may alter the pharmacokinetics or pharmacodynamics of some medications, which may require dose adjustment (examples include theophylline, warfarin, insulin). Neuropsychiatric symptoms: Suicidal thoughts and behaviors and suicide attempts have been reported in patients trying to quit smoking using Chamepex in post-marketing experience. Depressed mood, rarely including suicide attempts, may be a symptom of nicotine withdrawal. Chamepex should be used cautiously in patients with a history of seizures or other conditions likely to lower the seizure threshold. Discontinuation of treatment: At the end of treatment, stopping Chamepex has been associated with increased irritability, desire to smoke, depression, and/or insomnia in up to 3% of patients. Cardiovascular events: Inform your doctor of new or worsening cardiovascular symptoms. Pregnancy and breastfeeding: Pregnancy: Moderate data from women suggest no congenital anomalies or fetal/neonatal toxicity of varenicline. Animal studies have shown reproductive toxicity. As a precaution, it is preferable to avoid using varenicline during pregnancy. Breastfeeding: It is unknown whether varenicline is excreted in human breast milk. Animal studies indicate that varenicline is excreted in breast milk. The decision to continue or stop breastfeeding or to continue or stop Chamepex treatment should consider the benefits of breastfeeding for the baby and the benefits of Chamepex treatment for the woman. Patients with renal impairment: Dose adjustment is not necessary for patients with mild to moderate renal impairment. For patients with severe renal impairment, the recommended dose of Chamepex is 1 mg once daily. The dose should start at 0.5 mg once daily during the first three days, then increase to 1 mg once daily. Based on limited clinical experience with Chamepex in end-stage renal disease patients, treatment is not recommended in this group. Patients with hepatic impairment: Dose adjustment is not necessary for cirrhotic patients. Children: The safety of Chamepex has not yet been established in children or adolescents under 18 years. Components: Varenicline 0.5, 1 mg. Product details: Brand: Chamepex Quantity: 25 tablets Product form: Tablets Product type: Tablets